Agilent Technologies (A)

NYSE Health Care Life Sciences Tools & Services S&P 500

$174.76

+2.98 (+1.73%)

Close of Nov 06, 2026 · end-of-day data

Source: Agilent Technologies's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$4.20B	$4.47B	$4.91B	$5.16B	$5.34B	$6.32B	$6.85B	$6.83B	$6.51B	$6.95B
Cost of revenue	$2.00B	$2.06B	$2.23B	$2.36B	$2.50B	$2.91B	$3.13B	$3.37B	$2.98B	$3.31B
Gross profit	$2.20B	$2.41B	$2.68B	$2.81B	$2.84B	$3.41B	$3.72B	$3.46B	$3.54B	$3.64B
Research & development	$329.00M	$341.00M	$387.00M	$404.00M	$495.00M	$441.00M	$467.00M	$481.00M	$479.00M	$455.00M
Selling, general & admin	$1.25B	$1.25B	$1.39B	$1.46B	$1.50B	$1.62B	$1.64B	$1.63B	$1.57B	$1.71B
Operating income	$615.00M	$807.00M	$904.00M	$941.00M	$846.00M	$1.35B	$1.62B	$1.35B	$1.49B	$1.48B
Interest expense	$72.00M	$79.00M	$75.00M	$74.00M	$78.00M	$81.00M	$84.00M	$95.00M	$96.00M	$112.00M
Pre-tax income	$859.00M	$974.00M	$946.00M	$919.00M	$842.00M	$1.36B	$1.50B	$1.34B	$1.52B	$1.44B
Income tax	$82.00M	$119.00M	$630.00M	-$152.00M	$123.00M	$150.00M	$250.00M	$99.00M	$232.00M	$132.00M
Net income	$462.00M	$684.00M	$316.00M	$1.07B	$719.00M	$1.21B	$1.25B	$1.24B	$1.29B	$1.30B
EBITDA	$861.00M	$1.02B	$1.11B	$1.18B	$1.15B	$1.67B	$1.94B	$1.62B	$1.75B	$1.77B
EPS (basic)	$1.42	$2.12	$0.98	$3.41	$2.33	$3.98	$4.19	$4.22	$4.44	$4.59
EPS (diluted)	$1.40	$2.10	$0.97	$3.37	$2.30	$3.94	$4.18	$4.19	$4.43	$4.57
Diluted shares	329.00M	326.00M	325.00M	318.00M	312.00M	307.00M	300.00M	296.00M	291.00M	285.00M
Gross margin	52.3%	53.9%	54.5%	54.3%	53.1%	53.9%	54.4%	50.7%	54.3%	52.4%
Operating margin	14.6%	18.0%	18.4%	18.2%	15.8%	21.3%	23.6%	19.8%	22.9%	21.3%
Net margin	11.0%	15.3%	6.4%	20.7%	13.5%	19.1%	18.3%	18.1%	19.8%	18.8%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$2.29B	$2.68B	$2.25B	$1.38B	$1.44B	$1.48B	$1.05B	$1.59B	$1.33B	$1.79B
Receivables	$631.00M	$724.00M	$776.00M	$930.00M	$1.04B	$1.17B	$1.41B	$1.29B	$1.32B	$1.49B
Inventory	$533.00M	$575.00M	$638.00M	$679.00M	$720.00M	$830.00M	$1.04B	$1.03B	$972.00M	$1.02B
Total current assets	$3.63B	$4.17B	$3.85B	$3.19B	$3.42B	$3.80B	$3.78B	$4.19B	$3.96B	$4.59B
Goodwill	$2.52B	$2.61B	$2.97B	$3.59B	$3.60B	$3.98B	$3.95B	$3.96B	$4.48B	$4.47B
Total assets	$7.79B	$8.43B	$8.54B	$9.45B	$9.63B	$10.71B	$10.53B	$10.76B	$11.85B	$12.73B
Total current liabilities	$945.00M	$1.26B	$1.17B	$2.08B	$1.47B	$1.71B	$1.86B	$1.60B	$1.90B	$2.35B
Short-term debt	$0	$210.00M	$0	$616.00M	$75.00M	$0	$36.00M	$0	$45.00M	$304.00M
Long-term debt	$1.90B	$1.80B	$1.80B	$1.79B	$2.28B	$2.73B	$2.73B	$2.73B	$3.35B	$3.05B
Total debt	$1.90B	$2.01B	$1.80B	$2.41B	$2.36B	$2.73B	$2.77B	$2.73B	$3.39B	$3.35B
Total liabilities	$3.55B	$3.59B	$3.97B	$4.70B	$4.75B	$5.32B	$5.23B	$4.92B	$5.95B	$5.99B
Shareholders' equity	$4.24B	$4.83B	$4.57B	$4.75B	$4.87B	$5.39B	$5.30B	$5.84B	$5.90B	$6.74B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$793.00M	$889.00M	$1.09B	$1.02B	$921.00M	$1.49B	$1.31B	$1.77B	$1.75B	$1.56B
Capital expenditures	$139.00M	$176.00M	$177.00M	$155.00M	$119.00M	$188.00M	$291.00M	$298.00M	$378.00M	$407.00M
Free cash flow	$654.00M	$713.00M	$910.00M	$866.00M	$802.00M	$1.30B	$1.02B	$1.47B	$1.37B	$1.15B
Investing cash flow	-$238.00M	-$304.00M	-$705.00M	-$1.59B	-$147.00M	-$749.00M	-$338.00M	-$310.00M	-$1.26B	-$394.00M
Financing cash flow	-$268.00M	-$202.00M	-$797.00M	-$299.00M	-$717.00M	-$696.00M	-$1.37B	-$930.00M	-$752.00M	-$715.00M
Dividends paid	$150.00M	$170.00M	$191.00M	$206.00M	$222.00M	$236.00M	$250.00M	$265.00M	$274.00M	$282.00M
Share buybacks	$434.00M	$194.00M	$422.00M	$723.00M	$469.00M	$788.00M	$1.14B	$575.00M	$1.15B	$425.00M
Stock-based compensation	$58.00M	$60.00M	$70.00M	$72.00M	$83.00M	$110.00M	$125.00M	$111.00M	$129.00M	$128.00M
Depreciation & amortization	$246.00M	$212.00M	$210.00M	$238.00M	$308.00M	$321.00M	$317.00M	$271.00M	$257.00M	$288.00M

Income statement

quarters · USD

Quarter ended	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Revenue	$1.69B	$1.66B	$1.57B	$1.58B	$1.70B	$1.68B	$1.67B	$1.74B	$1.86B	$1.80B	$1.83B	$1.88B
Cost of revenue	$773.00M	$750.00M	$717.00M	$723.00M	$785.00M	$782.00M	$802.00M	$850.00M	$871.00M	$852.00M	$845.00M	$836.00M
Gross profit	$915.00M	$908.00M	$856.00M	$855.00M	$916.00M	$899.00M	$866.00M	$888.00M	$990.00M	$946.00M	$990.00M	$1.04B
Research & development	$114.00M	$128.00M	$113.00M	$127.00M	$111.00M	$113.00M	$112.00M	$111.00M	$119.00M	$117.00M	$126.00M	$123.00M
Selling, general & admin	$393.00M	$396.00M	$380.00M	$395.00M	$397.00M	$410.00M	$454.00M	$417.00M	$428.00M	$476.00M	$465.00M	$475.00M
Operating income	$408.00M	$384.00M	$363.00M	$333.00M	$408.00M	$376.00M	$300.00M	$360.00M	$443.00M	$353.00M	$399.00M	$444.00M
Interest expense	$22.00M	$22.00M	$20.00M	$22.00M	$32.00M	$28.00M	$29.00M	$28.00M	$27.00M	$25.00M	$25.00M	$29.00M
Pre-tax income	$420.00M	$403.00M	$374.00M	$343.00M	$401.00M	$367.00M	$260.00M	$366.00M	$442.00M	$364.00M	$408.00M	$444.00M
Income tax	-$55.00M	$55.00M	$66.00M	$61.00M	$50.00M	$49.00M	$45.00M	$30.00M	$8.00M	$59.00M	$69.00M	$82.00M
Net income	$475.00M	$348.00M	$308.00M	$282.00M	$351.00M	$318.00M	$215.00M	$336.00M	$434.00M	$305.00M	$339.00M	$362.00M
EBITDA	$470.00M	$446.00M	$426.00M	$396.00M	$477.00M	$448.00M	$373.00M	$432.00M	$514.00M	$420.00M	$466.00M	$510.00M
EPS (basic)	$1.63	$1.19	$1.05	$0.97	$1.23	$1.12	$0.75	$1.18	$1.54	$1.08	$1.20	$1.28
EPS (diluted)	$1.61	$1.18	$1.05	$0.97	$1.23	$1.11	$0.75	$1.18	$1.52	$1.07	$1.20	$1.28
Diluted shares	0	294.00M	293.00M	291.00M	-2.00M	287.00M	285.00M	285.00M	0	284.00M	283.00M	283.00M
Gross margin	54.2%	54.8%	54.4%	54.2%	53.9%	53.5%	51.9%	51.1%	53.2%	52.6%	54.0%	55.5%
Operating margin	24.2%	23.2%	23.1%	21.1%	24.0%	22.4%	18.0%	20.7%	23.8%	19.6%	21.7%	23.6%
Net margin	28.1%	21.0%	19.6%	17.9%	20.6%	18.9%	12.9%	19.3%	23.3%	17.0%	18.5%	19.3%

Balance sheet

quarters · USD

Quarter ended	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Cash & equivalents	$1.59B	$1.75B	$1.67B	$1.78B	$1.33B	$1.47B	$1.49B	$1.53B	$1.79B	$1.76B	$1.81B	$1.76B
Receivables	$1.29B	$1.29B	$1.25B	$1.23B	$1.32B	$1.33B	$1.37B	$1.38B	$1.49B	$1.52B	$1.50B	$1.48B
Inventory	$1.03B	$1.03B	$1.00B	$978.00M	$972.00M	$997.00M	$991.00M	$1.01B	$1.02B	$1.06B	$1.09B	$1.12B
Total current assets	$4.19B	$4.34B	$4.20B	$4.26B	$3.96B	$4.11B	$4.21B	$4.25B	$4.59B	$4.62B	$4.76B	$4.69B
Goodwill	$3.96B	$3.97B	$3.96B	$3.96B	$4.48B	$4.43B	$4.47B	$4.47B	$4.47B	$4.48B	$4.48B	$5.03B
Total assets	$10.76B	$10.95B	$10.86B	$11.00B	$11.85B	$11.91B	$12.16B	$12.23B	$12.73B	$12.81B	$13.06B	$13.97B
Total current liabilities	$1.60B	$1.62B	$1.96B	$2.39B	$1.90B	$1.87B	$2.01B	$1.89B	$2.35B	$2.23B	$2.27B	$2.29B
Short-term debt	$0	—	$420.00M	$795.00M	$45.00M	$16.00M	$146.00M	$59.00M	$304.00M	$304.00M	$304.00M	$304.00M
Long-term debt	$2.73B	$2.56B	$2.14B	$2.14B	$3.35B	$3.35B	$3.35B	$3.35B	$3.05B	$3.05B	$3.05B	$3.65B
Total debt	$2.73B	$2.56B	$2.56B	$2.93B	$3.39B	$3.36B	$3.50B	$3.41B	$3.35B	$3.35B	$3.35B	$3.95B
Total liabilities	$4.92B	$4.76B	$4.64B	$5.09B	$5.95B	$5.89B	$6.02B	$5.86B	$5.99B	$5.91B	$5.94B	$6.60B
Shareholders' equity	$5.84B	$6.19B	$6.21B	$5.90B	$5.90B	$6.03B	$6.14B	$6.37B	$6.74B	$6.91B	$7.12B	$7.36B

Cash flow

quarters · USD

Quarter ended	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Operating cash flow	$516.00M	$485.00M	$333.00M	$452.00M	$481.00M	$431.00M	$221.00M	$362.00M	$545.00M	$268.00M	$277.00M	$519.00M
Capital expenditures	$84.00M	$90.00M	$103.00M	$92.00M	$93.00M	$97.00M	$114.00M	$103.00M	$93.00M	$93.00M	$76.00M	$80.00M
Free cash flow	$432.00M	$395.00M	$230.00M	$360.00M	$388.00M	$334.00M	$107.00M	$259.00M	$452.00M	$175.00M	$201.00M	$439.00M
Investing cash flow	-$40.00M	-$95.00M	-$109.00M	-$100.00M	-$954.00M	-$94.00M	-$114.00M	-$96.00M	-$90.00M	-$93.00M	-$77.00M	-$1.03B
Financing cash flow	-$201.00M	-$240.00M	-$291.00M	-$246.00M	$25.00M	-$180.00M	-$116.00M	-$219.00M	-$200.00M	-$222.00M	-$144.00M	$471.00M
Dividends paid	$66.00M	$69.00M	$69.00M	$68.00M	$68.00M	$71.00M	$70.00M	$71.00M	$70.00M	$72.00M	$72.00M	$72.00M
Share buybacks	$80.00M	$0	$230.00M	$585.00M	$335.00M	$90.00M	$165.00M	$85.00M	$85.00M	$152.00M	$65.00M	$78.00M
Stock-based compensation	$14.00M	$44.00M	$31.00M	$28.00M	$26.00M	$40.00M	$30.00M	$32.00M	$26.00M	$41.00M	$32.00M	$32.00M
Depreciation & amortization	$62.00M	$62.00M	$63.00M	$63.00M	$69.00M	$72.00M	$73.00M	$72.00M	$71.00M	$67.00M	$67.00M	$66.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.